These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Peptides and anxiety: a dose-response evaluation of pentagastrin in healthy volunteers. McCann UD; Slate SO; Geraci M; Uhde TW Anxiety; 1994-1995; 1(6):258-67. PubMed ID: 9160584 [TBL] [Abstract][Full Text] [Related]
7. A dose-ranging study of the behavioral and cardiovascular effects of CCK-tetrapeptide in panic disorder. Bradwejn J; Koszycki D; Annable L; Couëtoux du Tertre A; Reines S; Karkanias C Biol Psychiatry; 1992 Nov; 32(10):903-12. PubMed ID: 1467375 [TBL] [Abstract][Full Text] [Related]
9. Pentagastrin has panic-inducing properties in obsessive compulsive disorder. de Leeuw AS; Den Boer JA; Slaap BR; Westenberg HG Psychopharmacology (Berl); 1996 Aug; 126(4):339-44. PubMed ID: 8878350 [TBL] [Abstract][Full Text] [Related]
10. Effect of medroxyprogesterone pretreatment on pentagastrin-induced panic symptoms in females with panic disorder. Le Mellédo J; Jhangri GS; Lott P; Tait GR; McManus K; Geddes M; Chrapko W; Lara N Psychiatry Res; 2001 Apr; 101(3):237-42. PubMed ID: 11311926 [TBL] [Abstract][Full Text] [Related]
11. Pentagastrin-induced sleep panic attacks: panic in the absence of elevated baseline arousal. Geraci M; Anderson TS; Slate-Cothren S; Post RM; McCann UD Biol Psychiatry; 2002 Dec; 52(12):1183-9. PubMed ID: 12488064 [TBL] [Abstract][Full Text] [Related]
12. Cholecystokinin and anxiety in normal volunteers: an investigation of the anxiogenic properties of pentagastrin and reversal by the cholecystokinin receptor subtype B antagonist L-365,260. Lines C; Challenor J; Traub M Br J Clin Pharmacol; 1995 Mar; 39(3):235-42. PubMed ID: 7619662 [TBL] [Abstract][Full Text] [Related]
13. Thyrotropin-releasing hormone: a potential comparator for the panicogenic effects of pentagastrin and CCK? Coupland N; Malizia A; Bailey J; Nutt D Biol Psychiatry; 1996 Mar; 39(6):465-6. PubMed ID: 8679797 [No Abstract] [Full Text] [Related]
14. A comparison of the effects of intravenous pentagastrin on patients with social phobia, panic disorder and healthy controls. McCann UD; Slate SO; Geraci M; Roscow-Terrill D; Uhde TW Neuropsychopharmacology; 1997 Mar; 16(3):229-37. PubMed ID: 9138439 [TBL] [Abstract][Full Text] [Related]
16. Cardiovascular and respiratory responses to a panicogenic agent in anaesthetised female Wistar rats at different stages of the oestrous cycle. Brack KE; Jeffery SM; Lovick TA Eur J Neurosci; 2006 Jun; 23(12):3309-18. PubMed ID: 16820020 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of pentagastrin-induced pressor response in conscious rats by the CCK-B receptor antagonist CI-988 and chlordiazepoxide. Webb JK; Rupniak NM; Boyce S Regul Pept; 1996 Jan; 61(1):71-6. PubMed ID: 8701030 [TBL] [Abstract][Full Text] [Related]
18. Effect of ethinyl estradiol on the panic response to the panicogenic agent pentagastrin. McManus K; Tait GR; Bellavance F; Le Mellédo JM J Affect Disord; 2001 Oct; 66(2-3):273-9. PubMed ID: 11578682 [TBL] [Abstract][Full Text] [Related]
19. Effect of prolonged ketamine exposure on cardiovascular physiology in pregnant and infant rhesus monkeys (Macaca mulatta). Hotchkiss CE; Wang C; Slikker W J Am Assoc Lab Anim Sci; 2007 Nov; 46(6):21-8. PubMed ID: 17994669 [TBL] [Abstract][Full Text] [Related]
20. Effects of propranolol on symptom and endocrine responses to pentagastrin. Khan S; Liberzon I; Abelson JL Psychoneuroendocrinology; 2004 Oct; 29(9):1163-71. PubMed ID: 15219640 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]